Ray Dalio Legend Biotech Corp Transaction History
Bridgewater Associates, LP
- $17.3 Billion
- Q3 2024
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Legend Biotech Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 165,975 shares of LEGN stock, worth $5.93 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
165,975
Previous 165,459
0.31%
Holding current value
$5.93 Million
Previous $7.33 Million
10.36%
% of portfolio
0.05%
Previous 0.04%
Shares
12 transactions
Others Institutions Holding LEGN
# of Institutions
227Shares Held
76.3MCall Options Held
199KPut Options Held
342K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$399 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$268 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$237 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$204 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$204 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.98B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...